Abcellera Biologics Inc
ABCL4.170USD
-0.050-1.18%
Close 09/08, 16:00（ET）Quotes delayed by 15 min
0.000USD0.000After-hours 09/09, 20:00 (ET)
1.25BMarket Cap
LossP/E TTM
Abcellera Biologics Inc
4.170
-0.050-1.18%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q2
FY2019Q4
Total revenue
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-57.40%9.18M
-93.49%6.60M
-78.10%10.06M
-96.15%12.19M
-84.54%21.55M
1740.65%101.38M
66.11%45.92M
56.15%316.58M
-32.98%139.33M
--5.51M
146.20%27.64M
--202.74M
6392.26%207.91M
--11.23M
--3.20M
Revenue
133.29%17.08M
-57.45%4.24M
-44.98%5.05M
-1.39%6.51M
-27.18%7.32M
-18.36%9.95M
-24.07%9.18M
-18.15%6.60M
-20.73%10.06M
27.48%12.19M
150.19%12.09M
51.60%8.06M
95.82%12.69M
-69.39%9.56M
-49.67%4.83M
--5.32M
-42.30%6.48M
--31.25M
199.81%9.60M
--11.23M
--3.20M
Operating expenses
-3.06%66.67M
3.16%66.89M
8.01%77.81M
10.87%68.17M
11.93%68.78M
-15.85%64.85M
21.42%72.03M
-3.39%61.49M
13.13%61.45M
-15.90%77.07M
2.67%59.32M
89.41%63.65M
56.63%54.31M
105.14%91.63M
22.58%57.78M
--33.60M
187.01%34.68M
--44.67M
810.20%47.13M
--12.08M
--5.18M
R&D expenses
-4.19%39.21M
8.17%42.50M
-5.24%46.08M
8.05%40.97M
12.21%40.93M
-25.38%39.29M
72.14%48.62M
42.64%37.92M
36.68%36.47M
99.68%52.65M
64.13%28.25M
52.33%26.58M
77.36%26.68M
113.46%26.37M
99.26%17.21M
--17.45M
64.55%15.05M
--12.35M
161.02%8.64M
--9.14M
--3.31M
Depreciation, depletion, and amortization
56.13%7.06M
36.35%6.61M
66.37%12.56M
-14.23%4.92M
-20.08%4.52M
-12.81%4.84M
-45.46%7.55M
11.10%5.74M
15.30%5.66M
38.69%5.56M
248.50%13.85M
39.44%5.16M
37.64%4.91M
21.21%4.01M
58.35%3.97M
--3.70M
299.22%3.56M
--3.31M
491.50%2.51M
--893.00K
--424.17K
Other operating expenses
----
----
100.00%0.00
---32.00M
---32.00M
----
-305.92%-3.20M
-100.00%0.00
-100.00%0.00
-100.00%0.00
-92.90%1.55M
--15.04M
44.32%5.21M
123.07%44.64M
-26.19%21.89M
--0.00
--3.61M
--20.01M
--29.66M
--0.00
--0.00
Operating profit
19.31%-49.59M
-14.15%-62.66M
-15.75%-72.75M
-12.34%-61.66M
-19.59%-61.45M
15.38%-54.89M
-66.37%-62.85M
-245.46%-54.89M
-512.07%-51.39M
-128.84%-64.87M
-146.32%-37.78M
234.31%37.73M
-19.38%-8.40M
42.31%224.95M
-49.27%81.55M
---28.10M
-723.54%-7.03M
--158.07M
8236.24%160.77M
---854.00K
---1.98M
Net non-operating interest income (expenses)
Non-operating interest income
-22.54%7.59M
-22.59%8.05M
-20.98%8.67M
-10.59%9.60M
-9.07%9.80M
6.58%10.40M
-31.78%10.97M
--10.74M
--10.78M
--9.76M
382.85%16.08M
----
----
----
3288.93%3.33M
----
--400.00K
----
123.17%98.26K
----
--44.03K
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
-22.58%4.04M
----
----
----
223.56%5.22M
----
----
----
1864.43%1.61M
--500.00K
--82.20K
Gains from sale of securities
----
----
----
----
----
----
----
----
----
----
----
----
----
340.00%1.20M
40.87%-855.00K
----
--800.00K
---500.00K
-792.31%-1.45M
----
---162.04K
Special income (expenses)
----
----
2385.71%17.40M
---32.00M
---32.00M
----
--700.00K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Other non-operating income (expenses)
-93.91%1.96M
-65.34%-2.53M
-364.23%-3.69M
776.69%17.94M
1732.28%32.16M
-142.55%-1.53M
89.19%-794.00K
-69.47%2.05M
-7780.00%-1.97M
771.59%3.59M
-1334.12%-7.34M
633.60%6.70M
97.18%-25.00K
-169.93%-535.00K
29750100.00%595.00K
---1.26M
-528.02%-886.00K
--765.00K
---2.00
--207.00K
----
Income before tax
22.26%-40.04M
-24.15%-57.14M
3.09%-50.37M
-57.05%-66.12M
-20.94%-51.50M
10.68%-46.02M
-57.09%-51.98M
-194.75%-42.10M
-405.64%-42.58M
-122.84%-51.52M
-141.67%-33.09M
251.39%44.44M
-25.33%-8.42M
42.49%225.62M
-49.69%79.40M
---29.35M
-485.79%-6.72M
--158.34M
7351.58%157.81M
---1.15M
---2.18M
Income tax
63.55%-5.31M
-112.79%-11.52M
-234.78%-16.16M
-11.28%-15.02M
-20.87%-14.57M
52.58%-5.41M
-51.16%-4.83M
-175.75%-13.49M
-636.67%-12.05M
-120.01%-11.41M
-116.42%-3.19M
323.44%17.81M
62.78%-1.64M
38.73%57.04M
-52.34%19.45M
---7.97M
44.00%-4.40M
--41.12M
7724.67%40.81M
---7.85M
---535.27K
Income after tax
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
--117.22M
7229.88%117.00M
--6.70M
---1.64M
Net income from continuous operations
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
--117.22M
7229.88%117.00M
--6.70M
---1.64M
Net income attributable to controlling interests
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
--117.22M
7229.88%117.00M
--6.70M
---1.64M
Net income attributable to common shareholders
5.97%-34.73M
-12.34%-45.62M
27.44%-34.21M
-78.63%-51.11M
-20.97%-36.93M
-1.25%-40.61M
-57.73%-47.15M
-207.46%-28.61M
-349.93%-30.53M
-123.79%-40.11M
-149.86%-29.89M
224.53%26.62M
-192.08%-6.79M
43.81%168.57M
-48.76%59.95M
---21.38M
-134.66%-2.32M
--117.22M
7229.88%117.00M
--6.70M
---1.64M
Basic earnings per share
7.31%-0.12
-10.47%-0.15
28.70%-0.12
-75.38%-0.17
-18.78%-0.13
0.47%-0.14
-55.49%-0.16
-205.92%-0.10
-343.43%-0.11
-123.47%-0.14
-149.14%-0.10
221.74%0.09
-179.37%-0.02
36.62%0.59
-51.05%0.21
---0.08
-133.80%-0.01
--0.43
7124.92%0.43
--0.03
---0.01
Diluted earnings per share
7.31%-0.12
-10.47%-0.15
28.70%-0.12
-75.38%-0.17
-18.78%-0.13
0.47%-0.14
-55.49%-0.16
-217.24%-0.10
-343.43%-0.11
-125.75%-0.14
-152.81%-0.10
209.98%0.08
-179.37%-0.02
47.87%0.54
-54.46%0.20
---0.08
-133.80%-0.01
--0.37
7124.92%0.43
--0.03
---0.01
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
